Abstract: Systems and methods are provided for thermally conductive shock absorbers for medical imaging probes. An example medical imaging probe may have, at least, a transducer disposed underneath a contact surface of the medical imaging probe, with the transducer configured to transmit and receive signals based on a medical imaging technique; a support structure disposed underneath the transducer; and a thermally conductive shock absorber (TCSA) layer disposed between the transducer and the support structure, with the thermally conductive shock absorber (TCSA) layer is configured to facilitate both of thermal transfer in a direction from the contact surface into the support structure, and absorbing at least a portion of impact force applied to at least the contact surface. The support structure may include a heat sink.

Abstract: Systems and methods are provided for thermally conductive shock absorbers for medical imaging probes. An example medical imaging probe may have, at least, a transducer disposed underneath a contact surface of the medical imaging probe, with the transducer configured to transmit and receive signals based on a medical imaging technique; a support structure disposed underneath the transducer; and a thermally conductive shock absorber (TCSA) layer disposed between the transducer and the support structure, with the thermally conductive shock absorber (TCSA) layer is configured to facilitate both of thermal transfer in a direction from the contact surface into the support structure, and absorbing at least a portion of impact force applied to at least the contact surface. The support structure may include a heat sink.

Abstract: The invention relates to a composition comprising a) at least one N-methyl-N-acylglucamine of formula (I), wherein R1 represents a linear or branched, saturated or unsaturated hydrocarbon chain with 7 to 21 carbon atoms, one or more organic acids of formula (II) and/or the salts thereof, R2—COOM, wherein R2 represents a linear or branched alkyl group or a linear or branched mono- or poly-unsaturated alkenyl group with 5 to 29 carbon atoms, and M represents hydrogen or one or more cations, wherein the cations are present in charge-equalizing amounts, and c) one or more alkanolamines of formula (III), wherein NR1R2R3R1, R2 and R3 represent hydrogen, a linear or branched alkyl group with 1 to 4 carbon atoms, a cycloalkyl group with 5 to 7 carbon atoms, a linear or branched hydroxyalkyl group with 2 to 5 carbon atoms and 1 or 2 hydroxy groups or a hydroxyether group with 2 to 6 carbon atoms, with the provision that at least one of the groups is a hydroxyalkyl group or a hydroxyether group.

Abstract: The invention relates to a composition comprising a) at least one N-methyl-N-acylglucamine of formula (I), wherein R1 represents a linear or branched, saturated or unsaturated hydrocarbon chain with 7 to 21 carbon atoms, one or more organic acids of formula (II) and/or the salts thereof, R2—COOM, wherein R2 represents a linear or branched alkyl group or a linear or branched mono- or poly-unsaturated alkenyl group with 5 to 29 carbon atoms, and M represents hydrogen or one or more cations, wherein the cations are present in charge-equalizing amounts, and c) one or more alkanolamines of formula (III), wherein NR1R2R3R1, R2 and R3 represent hydrogen, a linear or branched alkyl group with 1 to 4 carbon atoms, a cycloalkyl group with 5 to 7 carbon atoms, a linear or branched hydroxyalkyl group with 2 to 5 carbon atoms and 1 or 2 hydroxy groups or a hydroxyether group with 2 to 6 carbon atoms, with the provision that at least one of the groups is a hydroxyalkyl group or a hydroxyether group.

Abstract: The invention relates to the use of one or more M-methyl-N-acylglucamines of the formula (I) wherein R1 represents a linear or branched, saturated or unsaturated hydrocarbon group having 7 to 21 carbon atoms, as a corrosion inhibitor.